Ouro Fino Saúde Animal Participações S A : Institutional Presentation
December 07, 2020 at 03:03 pm EST
Share
August 2020
33 year history
1987
2000
2010
2014
2015
2018
Founded by
Entered in foot-
Intensification
of actions
Norival
and-mouth
abroad
Bonamichi and
disease
focusing on
Jardel Massari.
vaccine
Mexico and
market.
Colombia
Entered into
IPO
Inauguration of
biological plant
the pet market.
At the highest
and launch of
level of
the vaccine of
governance
circovirus.
2
Animal Health Global Market
9.6
2018 (US$ bi)
3o
5.4
1.6
1.4 1.1
0.4 0.3
Source: company information
3
Animal Health in Brazil
Market of
6 billion
reais (2018)
CAGR (13-18)
9 %
77%
53%
Production
21%
CAGR (13-18)
CAGR (13-18)
8 %
16 %
13%
2%11%
Others
Source: Sindan
4
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
Ourofino Saúde Animal Participações SA published this content on 07 December 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 December 2020 20:02:05 UTC
Ouro Fino Saude Animal Participacoes S.A., also known as Ourofino, is a Brazil-based company engaged in the animal health market business sector in Latin America. The Company manufactures veterinary products using scientific technology in the Company's laboratories. The Company's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.